Corvus Pharmaceuticals Stock Forecast

Buy or Hold candidate since Jun 24, 2026 Gain 13.59%

The Corvus Pharmaceuticals stock price fell by -6.13% on the last day (Monday, 13th Jul 2026) from $15.67 to $14.71. During the last trading day the stock fluctuated 6.02% from a day low at $14.70 to a day high of $15.59. The price has risen in 6 of the last 10 days and is up by 9.04% over the past 2 weeks. Volume has increased on the last day by 268 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $21.37 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -12.87% during the next 3 months and, with a 90% probability hold a price between $8.87 and $14.05 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

CRVS Signals & Forecast

The Corvus Pharmaceuticals stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $15.53. On a fall, the stock will find some support from the long-term average at approximately $13.05. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 09, 2026, and so far it has fallen -9.20%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Corvus Pharmaceuticals stock

On the downside, the stock finds support just below today's level from accumulated volume at $13.66 and $12.31. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Corvus Pharmaceuticals finds support just below today's level at $13.66. If this is broken, then the next support from accumulated volume will be at $12.31 and $11.50.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.89 between high and low, or 6.02%. For the last week, the stock has had daily average volatility of 5.41%.

Our recommended stop-loss: $14.03 (-4.62%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 2 days ago.)

Trading Expectations (CRVS) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect Corvus Pharmaceuticals to open at $15.00, and during the day (based on 14 day Average True Range), to move between $14.29 and $15.13, which gives a possible trading interval of +/-$0.83 (+/-5.82%) up or down from last closing price. If Corvus Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 5.82% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $13.66 (7.17%) than the resistance at $16.02 (8.91%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Corvus Pharmaceuticals stock A Buy?

Corvus Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: 0.406 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $15.00 ( 1.96%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk